Patents by Inventor Nicole Joy Horwood

Nicole Joy Horwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • sFRP and peptide motifs that interact with sFRP and methods of their use
    Patent number: 8334260
    Abstract: This disclosure relates to a peptide motif and proteins containing the motif that are capable of binding to secreted Frizzled-related protein family members. Accordingly, the disclosure also includes methods of regulating the interaction of sFRP-1 with proteins containing the motif.
    Type: Grant
    Filed: January 24, 2008
    Date of Patent: December 18, 2012
    Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, St. Vincent's Institute of Medical Research
    Inventors: Jeffrey S. Rubin, Aykut Üren, Brian K. Kay, Bernard Weisblum, Matthew Todd Gillespie, Nicole Joy Horwood
  • SFRP and peptide motifs that interact with SFRP and methods of their use
    Patent number: 7488710
    Abstract: This disclosure relates to a peptide motif and proteins containing the motif that are capable of binding to secreted Frizzled-related protein family members. Accordingly, the disclosure also includes methods of regulating the interaction of sFRP-1 with proteins containing the motif.
    Type: Grant
    Filed: January 10, 2002
    Date of Patent: February 10, 2009
    Assignees: The United States of America as represented by the Department of Health and Human Services, St. Vincent's Institute of Medical Research
    Inventors: Jeffrey S. Rubin, Aykut Üren, Matthew Todd Gillespie, Nicole Joy Horwood
  • SFRP AND PEPTIDE MOTIFS THAT INTERACT WITH SFRP AND METHODS OF THEIR USE
    Publication number: 20080145884
    Abstract: This disclosure relates to a peptide motif and proteins containing the motif that are capable of binding to secreted Frizzled-related protein family members. Accordingly, the disclosure also includes methods of regulating the interaction of sFRP-1 with proteins containing the motif.
    Type: Application
    Filed: January 24, 2008
    Publication date: June 19, 2008
    Inventors: Jeffrey S. Rubin, Aykut Oren, Brian K. Kay, Bernard Weisblum, Matthew Tood Gillespie, Nicole Joy Horwood
  • Method for treating a disease associated with excessive osteoclast formation
    Patent number: 6896880
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: May 24, 2005
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Matthew Todd Gillispie, Nicole Joy Horwood, Nobuyuki Udagawa, Masashi Kurimoto
  • Sfrp and peptide motifs that interact with sfrp and methods of their use
    Publication number: 20040077828
    Abstract: This disclosure relates to a peptide motif and proteins containing the motif that are capable of binding to secreted Frizzled-related protein family members. Accordingly, the disclosure also includes methods of regulating the interaction of sFRP-1 with proteins containing the motif.
    Type: Application
    Filed: July 10, 2003
    Publication date: April 22, 2004
    Inventors: Jeffrey S. Rubin, Aykut Uren, Brian K. Kay, Bernard Weisblum, Matthew Todd Gillespie, Nicole Joy Horwood
  • IL-18 AS AN OSTEOCLASTGENIC INHIBITOR
    Publication number: 20030095946
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Application
    Filed: February 25, 1998
    Publication date: May 22, 2003
    Inventors: MATTHEW TODD GILLSPIE, NICOLE JOY HORWOOD, NOBUYUKI UDAGAWA, MASASHI KURIMOTO
  • Osteoclastgenic inhibitory agent
    Publication number: 20020150555
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Application
    Filed: March 19, 2002
    Publication date: October 17, 2002
    Applicant: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
    Inventors: Matthew Todd Gillispie, Nicole Joy Horwood, Nobuyuki Udagawa, Masashi Kurimoto